About one in ten women experience depression during pregnancy or shortly after giving birth. This is among the most common complications related to pregnancy, and is generally treatable if recognized…
Read More
On August 4th, the U.S. Food and Drug Administration (FDA) approved zuranolone, the first oral medication designed to treat postpartum depression (PPD) in adults. The drug, which is rapid-acting, was…
Read More
Thanks to pioneering research spanning three generations led by BBRF Scientific Council member, three-time grantee and prizewinner Myrna Weissman, Ph.D., it is now widely accepted that children of…
Read More
It is estimated that 20% of women who have just given birth suffer from postpartum depression (PPD), and as many as one in three has depressive symptoms that affect them despite falling short of the…
Read More
Researchers have reported evidence from the brain suggesting that the way in which a new mother copes with her new parenting duties and the care of her infant can contribute to her own mental health…
Read More
